Rutherford, NJ., Dec. 30, 2025 (GLOBE NEWSWIRE) — Glucotrack, Inc. (Nasdaq: GCTK) (the “Company”), a medical technology company focused on the design,… Rutherford, NJ., Dec. 30, 2025 (GLOB...
Company to submit Investigational Device Exemption (IDE) to FDA for novel CBGM technology in Spring 2026 Expanded clinical advisory team with appointment… Company to submit Investigational Devic...
